K Gaarenstroom
- Naam
- Dr. K.N. Gaarenstroom
- Telefoon
- +31 71 526 3348
- k.n.gaarenstroom@umail.leidenuniv.nl
- Faculteit Geneeskunde
- Divisie 3
- Gynaecologie
- Kolk, W.L. van der; Zee, A.G.J. van der; Slomovitz, B.M.; Baldwin, P.J.W.; Doorn, H.C. van; Hullu, J.A. de; Velden, J. van der; Gaarenstroom, K.N.; Slangen, B.F.M.; Kjolhede, P.; Brannstrom, M.; Vergote, I.; Holland, C.M.; Coleman, R.; Dorst, E.B.L. van; Driel, W.J. van; Nunns, D.; Widschwendter, M.; Nugent, D.; DiSilvestro, P.A.; Mannel, R.S.; Tjiong, M.Y.; Boll, D.; Cibula, D.; Covens, A.; Provencher, D.; Runnebaum, I.B.; Monk, B.J.; Zanagnolo, V.; Tamussino, K.; Oonk, M.H.M.; Levenback, C.F.; Hermans, R.H.; Bouda, J.; Sharma, A.; Luesley, D.; Ellis, P.; Cruickshank, D.J.; Duncan, T.J.; Kieser, K.; Palle, C.; Spirtos, N.M.; O'Malley, D.M.; Leitao, M.M.; Geller, M.; Dhar, K.; Asher, V.; Tobias, D.H.; Borgfeldt, C.; Lea, J.S.; Lood, M.; Bailey, J.; Eyjolfsdottir, B.; Attard-Montalto, S.; Tewari, K.S.; Persson, P.; Manchanda, R.; Jensen, P.; , L. van le & GROINSS-V I II Participants (2022), Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe, Gynecologic Oncology 167(1): 3-10.
- Steenbeek, M.P.; Bommel, M.H.D. van; Bulten, J.; Hulsmann, J.A.; Bogaerts, J.; Garcia, C.; Cun, H.T.; Lu, K.H.; Beekhuizen, H.J. van; Minig, L.; Gaarenstroom, K.N.; Nobbenhuis, M.; Krajc, M.; Rudaitis, V.; Norquist, B.M.; Swisher, E.M.; Mourits, M.J.E.; Massuger, L.F.A.G.; Hoogerbrugge, N.; Hermens, R.P.M.G.; IntHout, J. & Hullu, J.A. de (2022), Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis, Journal of Clinical Oncology 40(17): 1879-+.
- Lof, P.; Retel, V.P.; Algera, M.D.; Gent, M.D.J.M. van; Gaarenstroom, K.N. & Driel, W.J. van (2022), Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice , Gynecologic Oncology 165(3): 459-465.
- Winden, L.J. van; Vermeulen, R.F.M.; Noort, V. van den; Gaarenstroom, K.N.; Kenter, G.G.; Brood-van Zanten, M.M.A.; Korse, C.M.; Beurden, M. van & Rossum, H.H. van (2022), Changes in sex steroids and relation with menopausal complaints in women undergoing risk-reducing salpingo-oophorectomy, Journal of the Endocrine Society 6(6).
- Algera, M.D.; Driel, W.J. van; Slangen, B.F.M.; Kruitwagen, R.F.P.M.; Wouters, M.W.J.M.; Baalbergen, A.; Cate, A.D. ten; Aalders, A.L.; Kolk, A. van der; Kruse, A.J.; Haaften-deJong, A.M.L.D. van; Swaluw, A.M.G. van de; Visschers, B.A.J.T.; Buis, C.C.N.; Gerestein, C.G.; Smeets, C.M.W.H.; Boll, D.; Laar, R. van de; Ngo, D.H.; Davelaar, E.; Ooms, E.A.; Dorst, E.B.L. van; Schmeink, C.E.; Es, E.J.M. van; Roes, E.M.; Cate, F.A. ten; Rijcken, F.E.M.; Rosier-van Dunne, F.M.R.; Fons, G.; Jansen, G.H.; Verhoeve, H.R.; Nagel, H.T.C.; Keizer, H.H.; Smedts, H.P.M.; Ebisch, I.M.W.; Lande, J. van de; Louwers, J.A.; Briet, J.; Waard, J. de; Diepstraten, J.; Vollebergh, J.H.A.; Avoort, I.A.M. van der; Dijk, J.E.W. van; Lange, J.G.; Mens, J.W.M.; Gaarenstroom, K.N.; Overmars, K.; Vries, L.C. de; Hofman, L.N.; Bartelink, L.R.; Huisman, M.A.; Verbruggen, M.B.; Vos, M.C.; Huisman, M.; Kleppe, M.; Hende, M. van den; Aa, M. van der; Wust, M.D.; Baas, M.I.; Engelen, M.J.A.; Scheers, E.C.A.H.; Moonen-Delarue, M.W.G.; Tjiong, M.Y.; Leffers, N.; Reesink, N.; Timmers, P.J.; Kolk, P.; Vencken, P.M.L.H.; Yigit, R.; Smit, R.A.; Westenberg, S.M.; Coppus, S.F.P.J.; Stam, T.C.; Schukken, T.K.; Baal, W.M. van; Minderhoud-Bassie, W.; Plas-Koning, Y.W.C.M. van der; Ham, M.A.P.C. van & Dutch Gynecological Oncology Colla (2022), Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the 'Dutch Gynecological Oncology Audit', Gynecologic Oncology 165(2): 330-338.
- Doorn, H.C. van; Oonk, M.H.M.; Fons, G.; Gaarenstroom, K.N.; Hullu, J. de; Rosmalen, J. van & Beekhuizen, H.J. van (2022), Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study, BMC Cancer 22(1).
- Wijk, L.M. van; Kramer, C.J.H.; Vermeulen, S.; Haar, N.T. ter; Jonge, M.M. de; Kroep, J.R.; Kroon, C.D. de; Gaarenstroom, K.N.; Vrieling, H.; Bosse, T. & Vreeswijk, M.P.G. (2021), The RAD51-FFPE test, Cancers 13(12): 2994.
- Bommel, M.H.D. van; Steenbeek, M.P.; IntHout, J.; Hermens, R.P.M.G.; Hoogerbrugge, N.; Harmsen, M.G.; Doorn, H.C. van; Mourits, M.J.E.; Beurden, M. van; Zweemer, R.P.; Gaarenstroom, K.N.; Slangen, B.F.M.; Brood-van Zanten, M.M.A.; Vos, M.C.; Piek, J.M.; Lonkhuijzen, L.R.C.W. van; Apperloo, M.J.A.; Coppus, S.F.P.J.; Prins, J.B.; Custers, J.A.E. & Hullu, J.A. de (2022), Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer, Supportive Care in Cancer 30.
- Steenbeek, M.P.; Bommel, M.H.D. van; Harmsen, M.G.; Hoogerbrugge, N.; Doorn, H.C. van; Keurentjes, J.H.M.; Beurden, M. van; Zweemer, R.P.; Gaarenstroom, K.N.; Penders, C.G.J.; Brood-van Zanten, M.M.A.; Vos, M.C.; Piek, J.M.; Lonkhuijzen, L.R.C.W. van; Apperloo, M.J.A.; Coppus, S.F.P.J.; IntHout, J.; Hullu, J.A. de & Hermens, R.P.M.G. (2021), Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy, Gynecologic Oncology 163(2): 371-377.
- Boer, F.L.; Eikelder, M.L.G. ten; Geloven, N. van; Kapiteijn, E.H.; Gaarenstroom, K.N.; Hughes, G.; Nooij, L.S.; Jozwiak, M.; Tjiong, M.Y.; Hullu, J.M.A. de; Galaal, K. & Poelgeest, M.I.E. van (2021), Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients, Gynecologic Oncology 161(1): 202-210.
- Terra, L.; Hooning, M.J.; Heemskerk-Gerritsen, B.A.M.; Beurden, M. van; Lennep, J.E.R. van; Doorn, H.C. van; Hullu, J.A. de; Mom, C.; Dorst, E.B.L. van; Mourits, M.J.E.; Slangen, B.F.M.; Gaarenstroom, K.N.; Zillikens, M.C.; Leiner, T.; Kolk, L. van der; Collee, M.; Wevers, M.; Ausems, M.G.E.M.; Engelen, K. van; Berger, L.P.; Asperen, C.J. van; Gomez-Garcia, E.B.; Beek, I. van de; Rookus, M.A.; Hauptmann, M.; Bleiker, E.M.; Schagen, S.B.; Aaronson, N.K.; Maas, A.H.E.M. & Leeuwen, F.E. van (2021), Long-term morbidity and health after early menopause due to oophorectomy in women at increased risk of ovarian cancer, JMIR Research Protocols 10(1).
- Deken, M.M.; Doorn, H.C. van; Verver, D.; Boogerd, L.S.F.; Valk, K.S. de; Rietbergen, D.D.D.; Poelgeest, M.I.E. van; Kroon, C.D. de; Beltman, J.J.; Leeuwen, F.W.B. van; Putter, H.; Braak, J.P.B.M.; Geus-Oei, L.F. de; Velde, C.J.H. van de; Burggraaf, J.; Vahrmeijer, A.L. & Gaarenstroom, K.N. (2020), Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer, Gynecologic Oncology 159(3): 672-680.
- Wijk, L.M. van; Vermeulen, S.; Meijers, M.; Diest, M.F. van; Haar, N.T. ter; Jonge, M.M. de; Solleveld-Westerink, N.; Wezel, T. van; Gent, D.C. van; Kroep, J.R.; Bosse, T.; Gaarenstroom, K.N.; Vrieling, H. & Vreeswijk, M.P.G. (2020), The RECAP test rapidly and reliably identifies homologous recombination-deficient ovarian carcinomas, Cancers 12(10).
- Muynck, L.D.A.N. de; Gaarenstroom, K.N.; Sier, C.F.M.; Duijvenvoorde, M. van; Bosse, T.; Mieog, J.S.D.; Kroon, C.D. de; Vahrmeijer, A.L. & Peters, I.T.A. (2020), Novel Molecular Targets for Tumor-Specific Imaging of Epithelial Ovarian Cancer Metastases, Cancers 12(6).
- Muynck, L.D.A.N. de; Gaarenstroom, K.N.; Sier, C.F.M.; Duijvenvoorde, M. van; Bosse, T.; Mieog, J.S.D.; Kroon, C.D. de; Vahrmeijer, A.L. & Peters, I.T.A. (2020), Novel Molecular Targets for Tumor-Specific Imaging of Epithelial Ovarian Cancer Metastases, Cancers 12(6).
- Tesfai, F.M.; Kroep, J.R.; Gaarenstroom, K.; Kroon, C. de; Loenhout, R. van; Smit, V.; Trimbos, B.; Nout, R.A.; Poelgeest, M.I.E. van & Beltman, J.J. (2020), Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy, International Journal of Gynecological Cancer 30(1): 115-121.
- Kopper, O.; Witte, C.J. de; Lohmussaar, K.; Valle-Inclan, J.E.; Hami, N.; Kester, L.; Balgobind, A.V.; Korving, J.; Proost, N.; Begthel, H.; Wijk, L.M. van; Revilla, S.A.; Theeuwsen, R.; Ven, M. van de; Roosmalen, M.J. van; Ponsioen, B.; Ho, V.W.H.; Neel, B.G.; Bosse, T.; Gaarenstroom, K.N.; Vrieling, H.; Vreeswijk, M.P.G.; Diest, P.J. van; Witteveen, P.O.; Jonges, T.; Bos, J.L.; Oudenaarden, A. van; Zweemer, R.P.; Snippert, H.J.G.; Kloosterman, W.P. & Clevers, H. (2019), An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity, Nature Medicine 25(5): 838-+.
- Hoogstins, C.E.S.; Boogerd, L.S.F.; Gaarenstroom, K.N.; Kroon, C.D. de; Beltman, J.J.; Trimbos, J.B.M.Z.; Bosse, T.; Vuyk, J.; Low, P.S.; Burggraaf, J. & Vahrmeijer, A.L. (2019), Feasibility of folate receptor-targeted intraoperative fluorescence imaging during staging procedures for early ovarian cancer, European Journal of Gynaecological Oncology 40(2): 203-208.
- Vermeulen, R.F.M.; Beurden, M. van; Gaarenstroom, K.N.; Teunis, T.; Kieffer, J.M.; Aaronson, N.K.; Kenter, G.G. & Korse, C.M. (2018), Does anti-Mullerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy? A prospective observational study, Climacteric 21(6): 574-580.
- Jonge, M.M. de; Ruano, D.; Eijk, R. van; Stoep, N. van der; Nielsen, M.; Wijnen, J.T.; Haar, N.T. ter; Baalbergen, A.; Bos, M.E.M.M.; Kagie, M.J.; Vreeswijk, M.P.G.; Gaarenstroom, K.N.; Kroep, J.R.; Smit, V.T.H.B.M.; Bosse, T.; Wezel, T. van & Asperen, C.J. van (2018), Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue, Journal of Molecular Diagnostics 20(5): 600-611.
- Woolderink, J.M.; Bock, G.H. de; Hullu, J.A. de; Hollema, H.; Zweemer, R.P.; Slangen, B.F.M.; Gaarenstroom, K.N.; Beurden, M. van; Doom, H.C. van; Sijmons, R.H.; Vasen, H.F.A. & Mourits, M.J.E. (2018), Characteristics of Lynch syndrome associated ovarian cancer, Gynecologic Oncology 150(2): 324-330.
- Hoeven, N.M.A. van der; Wijk, K. van; Bonfrer, S.E.; Beltman, J.J.; Louwe, L.A.; Kroon, C.D. de; Asperen, C.J. van & Gaarenstroom, K.N. (2018), Outcome and Prognostic Impact of Surgical Staging in Serous Tubal Intraepithelial Carcinoma: A Cohort Study and Systematic Review, Clinical Oncology 30(8): 463-471.
- Harmsen, M.G.; Steenbeek, M.P.; Hoogerbrugge, N.; Doorn, H.C. van; Gaarenstroom, K.N.; Vos, M.C.; Massuger, L.F.A.G.; Hullu, J.A. de & Hermens, R.P.M.G. (2018), A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing, Health Expectations 21(3): 659-667.
- Boogerd, L.S.F.; Hoogstins, C.E.S.; Gaarenstroom, K.N.; Kroon, C.D. de; Beltman, J.J.; Bosse, T.; Stelloo, E.; Vuyk, J.; Low, P.S.; Burggraaf, J. & Vahrmeijer, A.L. (2018), Folate receptor-alpha targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study, Oncotarget 9(1): 791-801.
- Helder-Woolderink, J.; Bock, G. de; Hullu, J. de; Hollema, H.; Zweemer, R.; Slangen, B.; Gaarenstroom, K.; Beurden, M. van; Doorn, L. van; Sijmons, R.; Vasen, H. & Mourits, M. (2017), CHARACTERISTICS OF OVARIAN CANCER IN WOMEN WITH LYNCH SYNDROME, International Journal of Gynecological Cancer 27: 245-245.
- Helder-Woolderink, J.; Bock, G. de; Hullu, J. de; Hollema, H.; Zweemer, R.; Slangen, B.; Gaarenstroom, K.; Beurden, M. van; Doorn, L. van; Sijmons, R.; Vasen, H. & Mourits, M. (2017), CHARACTERISTICS OF OVARIAN CANCER IN WOMEN WITH LYNCH SYNDROME, International Journal of Gynecological Cancer 27: 90-90.
- Steenbeek, M.P.; Harmsen, M.G.; Hoogerbrugge, N.; Jong, M.A.D.; Maas, A.H.E.M.; Prins, J.B.; Bulten, J.; Teerenstra, S.; Piek, J.M.; Doorn, H.C. van; Beurden, M. van; Mourits, M.J.E.; Zweemer, R.P.; Gaarenstroom, K.N.; Slangen, B.F.M.; Vos, C.M.; Lonkhuijzen, L.R.C.W. van; Massuger, L.F.A.G.; Hermens, R.P.M.G. & Hullu, J.A. de (2017), DECISION MAKING FOR RISK-REDUCING SURGERY IN BRCA1/2 MUTATION CARRIERS IN THE PROSPECTIVE MULTICENTRE TUBA STUDY, International Journal of Gynecological Cancer 27: 2020-2020.
- Pouwer, A.W.; Hinten, F.; Velden, J. van der; Smolders, R.G.V.; Slangen, B.F.M.; Zijlmans, H.J.M.A.A.; IntHout, J.; Zee, A.G.J. van der; Boll, D.; Gaarenstroom, K.N.; Arts, H.J.G. & Hullu, J.A. de (2017), VOLUME-CONTROLLED VERSUS SHORT DRAINAGE AFTER INGUINOFEMORAL LYMPHADENECTOMY IN VULVAR CANCER PATIENTS. A NATIONWIDE STUDY OF THE DUTCH GYNAECOLOGIC ONCOLOGY GROUP, International Journal of Gynecological Cancer 27: 586-586.
- Pouwer, A.W.; Hinten, F.; Velden, J. van der; Smolders, R.G.V.; Slangen, B.F.M.; Zijlmans, H.J.M.A.A.; IntHout, J.; Zee, A.G.J. van der; Boll, D.; Gaarenstroom, K.N.; Arts, H.J.G. & Hullu, J.A. de (2017), VOLUME-CONTROLLED VERSUS SHORT DRAINAGE AFTER INGUINOFEMORAL LYMPHADENECTOMY IN VULVAR CANCER PATIENTS. A NATIONWIDE STUDY OF THE DUTCH GYNAECOLOGIC ONCOLOGY GROUP, International Journal of Gynecological Cancer 27: 1884-1884.
- Vermeulen, R.F.M.; Beurden, M. van; Kieffer, J.M.; Bleiker, E.M.A.; Valdimarsdottir, H.B.; Massuger, L.F.A.G.; Mourits, M.J.E.; Gaarenstroom, K.N.; Dorst, E.B.L. van; Putten, H.W.H.M. van der & Aaronson, N.K. (2017), Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study, European Journal of Cancer 84: 159-167.
- Gent, M.D.J.M. van; Rademaker, M.; Veer, J.C.B. van der; Poelgeest, M.I.E. van; Gaarenstroom, K.N.; Putter, H.; Trimbos, J.B.M.Z. & Kroon, C.D. de (2017), Long-Term Oncological Outcome After Conventional Radical Hysterectomy Versus 2 Nerve-Sparing Modalities for Early Stage Cervical Cancer, International Journal of Gynecological Cancer 27(8): 1729-1736.
- Vrie, R. van de; Meurs, H.S. van; Rutten, M.J.; Naaktgeboren, C.A.; Opmeer, B.C.; Gaarenstroom, K.N.; Gorp, T. van; Brugge, H.G. ter; Hofhuis, W.; Schreuder, H.W.R.; Arts, H.J.G.; Zusterzeel, P.L.M.; Pijnenborg, J.M.A.; Haaften, M. van; Engelen, M.J.A.; Boss, E.A.; Vos, M.C.; Gerestein, K.G.; Schutter, E.M.J.; Kenter, G.G.; Bossuyt, P.M.M.; Mol, B. & Buist, M.R. (2017), Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer, Gynecologic Oncology 146(3): 449-456.
- Aiyer, K.; Bartosch, C.; Cohen, D.; Dreef, E.; Nielsen, M.; Oliva, E.; Gaarenstroom, K.; Kroon, C. de; Smit, V. & Bosse, T. (2017), Mismatch repair deficient gland foci in histologically normal endometrium of Lynch syndrome patients, Virchows Archiv 471: S81-S81.
- Pouwer, A.W.; Hinten, F.; Velden, J. van der; Smolders, R.G.V.; Slangen, B.F.M.; Zijlmans, H.J.M.A.A.; IntHout, J.; Zee, A.G.J. van der; Boll, D.; Gaarenstroom, K.N.; Arts, H.J. & Hullu, J.A. de (2017), Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar cancer patients: A Dutch nationwide prospective study, Gynecologic Oncology 146(3): 580-587.
- Rutten, M.J.; Meurs, H.S. van; Vrie, R. van de; Gaarenstroom, K.N.; Naaktgeboren, C.A.; Gorp, T. van; Brugge, H.G. ter; Hofhuis, W.; Schreuder, H.W.R.; Arts, H.J.G.; Zusterzeel, P.L.M.; Pijnenborg, J.M.A.; Haaften, M. van; Fons, G.; Engelen, M.J.A.; Boss, E.A.; Vos, M.C.; Gerestein, K.G.; Schutter, E.M.J.; Opmeer, B.C.; Spijkerboer, A.M.; Bossuyt, P.M.M.; Mol, B.; Kenter, G.G. & Buist, M.R. (2017), Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial, Journal of Clinical Oncology 35(6): 613-+.
- Zaaijer, L.H.; Doorn, H.C. van; Mourits, M.J.E.; Beurden, M. van; Hullu, J.A. de; Adank, M.A.; Lonkhuijzen, L.R.C.W. van; Vasen, H.F.A.; Slangen, B.F.M.; Gaarenstroom, K.N.; Zweemer, R.P.; Vencken, P.M.L.H.; Seynaeve, C. & Kriege, M. (2016), Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers, British Journal of Cancer 115(10): 1174-1178.
- Jonge, M. de; Eijk, R. van; Ruano, D.; Wijnen, J.; Stoep, N. van der; Nielsen, M.; Gaarenstroom, K.; Kroep, J.; Wezel, T. van; Bosse, T. & Asperen, C. van (2016), BRCA1/2 mutational analysis on formalin fixed paraffin embedded (FFPE) ovarian tumour DNA, International Journal of Gynecological Cancer 26: 129-129.
- Nooij, L.S.; Brand, F.A.M.; Gaarenstroom, K.N.; Creutzberg, C.L.; Hullu, J.A. de & Poelgeest, M.I.E. van (2016), Risk factors and treatment for recurrent vulvar squamous cell carcinoma, Critical Reviews in Oncology/Hematology 106: 1-13.
- Nooij, L.S.; Slot, M.A. van der; Dekkers, O.M.; Stijnen, T.; Gaarenstroom, K.N.; Creutzberg, C.L.; Smit, V.T.H.B.M.; Bosse, T. & Poelgeest, M.I.E. van (2016), Tumour-free margins in vulvar squamous cell carcinoma: Does distance really matter?, European Journal of Cancer 65: 139-149.
- Heeren, A.M.; Punt, S.; Bleeker, M.C.; Gaarenstroom, K.N.; Velden, J. van der; Kenter, G.G.; Gruijl, T.D. de & Jordanova, E.S. (2016), Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix, Modern Pathology 29(7): 753-763.
- Hoogstins, C.E.S.; Tummers, Q.R.J.G.; Gaarenstroom, K.N.; Kroon, C.D. de; Trimbos, J.B.M.Z.; Bosse, T.; Smit, V.T.H.B.M.; Vuyk, J.; Velde, C.J.H. van de; Cohen, A.F.; Low, P.S.; Burggraaf, J. & Vahrmeijer, A.L. (2016), A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer, Clinical Cancer Research 22(12): 2929-2938.
- Tummers, Q.R.J.G.; Hoogstins, C.E.S.; Gaarenstroom, K.N.; Kroon, C.D. de; Poelgeest, M.I.E. van; Vuyk, J.; Bosse, T.; Smit, V.T.H.B.M.; Velde, C.J.H. van de; Cohen, A.F.; Low, P.S.; Burggraaf, J. & Vahrmeijer, A.L. (2016), Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17, Oncotarget 7(22): 32144-32155.
- Doorn, H.C. van; Beekhuizen, H.J. van; Gaarenstroom, K.N.; Velden, J. van der; Zee, A.G.J. van der; Oonk, M.H.M. & Hullu, J.A. de (2016), Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible, Gynecologic Oncology 140(3): 415-419.
- Soletormos, G.; Duffy, M.J.; Abu Hassan, S.O.; Verheijen, R.H.M.; Tholander, B.; Bast, R.C.; Gaarenstroom, K.N.; Sturgeon, C.M.; Bonfrer, J.M.; Petersen, P.H.; Troonen, H.; CarloTorre, G.; Kulpa, J.K.; Tuxen, M.K. & Molina, R. (2016), Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer Updated Guidelines From the European Group on Tumor Markers, International Journal of Gynecological Cancer 26(1): 43-51.
- Grootenhuis, N.C. te; Zee, A.G.J. van der; Doorn, H.C. van; Velden, J. van der; Vergote, I.; Zanagnolo, V.; Baldwin, P.J.; Gaarenstroom, K.N.; Dorst, E.B. van; Trum, J.W.; Slangen, B.F.M.; Runnebaum, I.B.; Tamussino, K.; Hermans, R.H.; Provencher, D.M.; Bock, G.H. de; Hullu, J.A. de & Oonk, M.H.M. (2016), Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I, Gynecologic Oncology 140(1): 8-14.
- Nooij, L.S.; Ongkiehong, P.J.; Zwet, E.W. van; Bosse, T.; Creutzberg, C.L.; Gaarenstroom, K.N. & Poelgeest, M.I.E. van (2015), Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma, Gynecologic Oncology 139(3): 458-464.
- Gaarenstroom, K.N.; Hoogstins, C.E.S.; Tummers, Q.R.J.G.; Kroon, C.D. de; Beltman, J.J.; Poelgeest, M.I.E. van; Trimbos, J.B.; Bosse, T.; Burggraaf, J.; Smit, V.T.H.B.; Vuyk, J.; Cohen, A.F.; Velde, C.J.H. van de; Low, P.S. & Vahrmeijer, A.L. (2015), A NOVEL TUMOR SPECIFIC AGENT FOR FLUORESCENCE GUIDED SURGERY IN EPITHELIAL OVARIAN CANCER: FIRST IN HUMAN EXPERIENCE, International Journal of Gynecological Cancer 25(9): 445-446.
- Hinten, F.; Velden, J. van der; Smolders, R.G.V.; Slangen, B.F.M.; Zijlmans, H.; IntHout, J.; Zee, A.G.J. van der; Boll, D.; Gaarenstroom, K.N.; Arts, H.J.G. & Hullu, J.A. de (2015), DUTCH GYNECOLOGIC ONCOLOGY GROUP STUDY: MEASUREMENT AND MORBIDITY OF THE BODY AFTER GROIN LYMPHADENECTOMY (MAMBO) IA: LONG DRAINAGE AFTER INGUINOFEMORAL LYMPHADENECTOMY IN VULVAR CANCER PATIENTS, International Journal of Gynecological Cancer 25(9): 675-676.
- Doorn, H.C. van; Beekhuizen, H.J. van; Gaarenstroom, K.N.; Velde, J. van der; Oonk, M.H.M.; Zee, A.G.J. van der & Hullu, J.A. de (2015), FEASIBILITY OF REPEAT SENTINEL LYMPH NODE (SLN) PROCEDURE IN PATIENTS WITH RECURRENT VULVAR SQUAMOUS CELL CARCINOMA, International Journal of Gynecological Cancer 25(9): 689-690.
- Buist, M.R.; Vrie, R. van de; Rutten, M.J.; Meurs, H.S. van; Gaarenstroom, K.J.; Gorp, T. van; Brugge, H.G. ter; Hofhuis, W.; Schreuder, H.W.R.; Arts, H.J.G.; Zusterzeel, P.; Pijnenborg, J.M.A.; Haaften, M. van; Fons, G.; Mol, B.W. & Kenter, G.G. (2015), LAPAROSCOPY TO PREDICT THE RESULT OF PRIMARY CYTOREDUCTIVE SURGERY IN ADVANCED OVARIAN CANCER (LAPOVCA): A MULTICENTRE RANDOMISED CONTROLLED TRIAL, International Journal of Gynecological Cancer 25(9): 102-103.
- Nooij, L.S.; Ongkiehong, P.J.; Zwet, E.W. van; Bosse, T.; Creutzberg, C.L.; Gaarenstroom, K.N. & Poelgeest, M.I.E. van (2015), NODAL DEBULKING VERSUS FULL INGUINOFEMORAL LYMPHADENECTOMY AND RISK OF RECURRENCE IN LYMPH NODE POSITIVE VULVAR SQUAMOUS CELL CARCINOMA PATIENTS, International Journal of Gynecological Cancer 25(9): 680-680.
- Grootenhuis, N.C. te; Zee, A.G.J. van der; Doorn, H.C. van; Velden, J. van der; Vergote, I.; Zanagnolo, V.; Baldwin, P.J.; Gaarenstroom, K.N.; Dorst, E.B. van; Trum, J.W.; Slangen, B.F.M.; Runnebaum, I.B.; Tamussino, K.; Hermans, R.H.; Provencher, D.M.; Hullu, J.A. de & Oonk, M.H.M. (2015), SENTINEL NODES AND VULVAR CANCER: LONG-TERM FOLLOW-UP OF THE GRONINGEN INTERNATIONAL STUDY ON SENTINEL NODES IN VULVAR CANCER (GROINSS-V-I), International Journal of Gynecological Cancer 25(9): 82-83.
- Harmsen, M.G.; Arts-de Jong, M.; Hoogerbrugge, N.; Maas, A.H.E.M.; Prins, J.B.; Bulten, J.; Teerenstra, S.; Adang, E.M.M.; Piek, J.M.J.; Doorn, H.C. van; Beurden, M. van; Mourits, M.J.E.; Zweemer, R.P.; Gaarenstroom, K.N.; Slangen, B.F.M.; Vos, M.C.; Lonkhuijzen, L.R.C.W. van; Massuger, L.F.A.G.; Hermens, R.P.M.G. & Hullu, J.A. de (2015), Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study, BMC Cancer 15.
- Verbeek, F.P.R.; Tummers, Q.R.J.G.; Rietbergen, D.D.D.; Peters, A.A.W.; Schaafsma, B.E.; Velde, C.J.H. van de; Frangioni, J.V.; Leeuwen, F.W.B. van; Gaarenstroom, K.N. & Vahrmeijer, A.L. (2015), Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance, International Journal of Gynecological Cancer 25(6): 1086-1093.
- Tummers, Q.R.J.G.; Hoogstins, C.E.S.; Peters, A.A.W.; Kroon, C.D. de; Trimbos, J.B.M.Z.; Velde, C.J.H. van de; Frangioni, J.V.; Vahrmeijer, A.L. & Gaarenstroom, K.N. (2015), The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer.
- Trietsch, M.D.; Nooij, L.S.; Gaarenstroom, K.N. & Poelgeest, M.I.E. van (2015), Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: A review of the current literature, Gynecologic Oncology 136(1): 143-157.
- Handgraaf, H.J.M.; Verbeek, F.P.R.; Tummers, Q.R.G.; Boogerd, L.S.F.; Velde, C.J.H. van de; Vahrmeijer, A.L. & Gaarenstroom, K.N. (2014), Real-time near-infrared fluorescence guided surgery in gynecologic oncology: A review of the current state of the art, Gynecologic Oncology 135(3): 606-613.
- Hinten, F.; Velden, J. van der; Smolders, R.G.V.; Slangen, B.F.M.; Zijlmans, H.; IntHout, J.; Boll, D.; Gaarenstroom, K.N.; Arts, H.J.G. & Hullu, J.A. de (2014), DGOG STUDY: MEASUREMENT AND MORBIDITY OF THE BODY AFTER GROIN LYMPHADENECTOMY (MAMBO) IA: LONG DRAINAGE AFTER INGUINOFEMORAL LYMPHADENECTOMY IN WOMEN WITH VULVAR CANCER, International Journal of Gynecological Cancer 24(9): 925-926.
- Rijkmans, E.C.; Nout, R.A.; Rutten, I.H.H.M.; Ketelaars, M.; Neelis, K.J.; Laman, M.S.; Coen, V.L.M.A.; Gaarenstroom, K.N.; Kroep, J.R. & Creutzberg, C.L. (2014), Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy, Gynecologic Oncology 135(2): 231-238.
- Trietsch, M.D.; Jordanova, Z.; Peters, A.A.W.; Gaarenstroom, K.N.; Fleuren, G.J. & Bosse, T. (2014), L1CAM EXPRESSION IS ASSOCIATED WITH A WORSE PROGNOSIS IN VULVAR SQUAMOUS CELL CARCINOMA, International Journal of Gynecological Cancer 24(9): 902-903.
- Rademaker, M.; Tillaart, S.A. van den; Poelgeest, M.I. van; Beltman, J.J.; Gaarenstroom, K.N.; Peters, A.A.W.; Trimbos, J.B. & Kroon, C.D. de (2014), LONG-TERM FOLLOW-UP AFTER NERVE SPARING RADICAL HYSTERECTOMY IN PATIENTS WITH STAGE IA-IIA CERVICAL CANCER, International Journal of Gynecological Cancer 24(9): 3-3.
- Trietsch, M.D.; Spaans, V.M.; Haar, N.T. ter; Osse, E.M.; Peters, A.A.W.; Gaarenstroom, K.N. & Fleuren, G.J. (2014), CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma, Gynecologic Oncology 135(1): 149-155.
- Hellendoorn-van Vreeswijk, J.; Gaarenstroom, K.; Smit, Y. & Stemkens, D. (2014), LESS FREQUENT FOLLOW-UP AFTER PRIMARY CERVICAL CANCER TREATMENT, BETTER PATIENT CARE?, International Journal of Gynecological Cancer 24(8): 34-34.
- Gent, M.D.J.M. van; Haak, L.W. van den; Gaarenstroom, K.N.; Peters, A.A.W.; Poelgeest, M.I.E. van; Trimbos, J.B.M.Z. & Kroon, C.D. de (2014), Nerve-Sparing Radical Abdominal Trachelectomy Versus Nerve-Sparing Radical Hysterectomy in Early-Stage (FIGO IA2-IB) Cervical Cancer A Comparative Study on Feasibility and Outcome, International Journal of Gynecological Cancer 24(4): 735-743.
- Laar, R. van de; Zusterzeel, P.L.M.; Gorp, T. van; Buist, M.R.; Driel, W.J. van; Gaarenstroom, K.N.; Arts, H.J.G.; Huisseling, J.C.M. van; Hermans, R.H.M.; Pijnenborg, J.M.A.; Schutter, E.M.J.; Pelikan, H.M.P.; Vollebergh, J.H.A.; Engelen, M.J.A.; IntHout, J.; Kruitwagen, R.F.P.M. & Massuger, L.F.A.G. (2014), Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum- sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study, BMC Cancer 14.
- Trietsch, M.D.; Spaans, V.M.; Haar, N.T. ter; Osse, E.M.; Peters, A.A.W.; Gaarenstroom, K.N. & Fleuren, G.J. (2013), CDKN2A (P16) AND HRAS ARE FREQUENTLY MUTATED IN VULVAR SQUAMOUS CELL CARCINOMA, International Journal of Gynecological Cancer 23(8).
- Haak, L. van den; Nagelkerken, A.I.; Tillaart, S.A.H.M. van den; Poelgeest, M.I.E. van; Gaarenstroom, K.N.; Peeters, A.A.W.; Trimbos, J.B. & Kroon, C.D. de (2013), LOCAL RECURRENCE AFTER NERVE SPARING RADICAL HYSTERECTOMY FOR STAGE IA2-IIA CERVICAL CARCINOMA: PROSPECTIVE COMPARISON OF 2 SURGICAL TECHNIQUES., International Journal of Gynecological Cancer 23(8).
- Trietsch, M.D.; Peters, A.A.W.; Gaarenstroom, K.N.; Koningsbrugge, S.H.L. van; Haar, N.T. ter; Osse, E.M.; Halbesma, N. & Fleuren, G.J. (2013), Spindle cell morphology is related to poor prognosis in vulvar squamous cell carcinoma, British Journal of Cancer 109(8): 2259-2265.
- Verbeek, F.P.R.; Vorst, J.R. van der; Schaafsma, B.E.; Swijnenburg, R.J.; Gaarenstroom, K.N.; Elzevier, H.W.; Velde, C.J.H. van de; Frangioni, J.V. & Vahrmeijer, A.L. (2013), Intraoperative Near Infrared Fluorescence Guided Identification of the Ureters Using Low Dose Methylene Blue: A First in Human Experience, Journal of Urology, The 190(2): 574-579.
- Vencken, P.M.L.H.; Reitsma, W.; Kriege, M.; Mourits, M.J.E.; Bock, G.H. de; Hullu, J.A. de; Altena, A.M. van; Gaarenstroom, K.N.; Vasen, H.F.A.; Adank, M.A.; Schmidt, M.K.; Beurden, M. van; Zweemer, R.P.; Rijcken, F.; Slangen, B.F.M.; Burger, C.W. & Seynaeve, C. (2013), Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands, Annals of Oncology 24(8): 2036-2042.
- Hennink, S.D.; Hofland, N.; Gopie, J.P.; Kaa, C. van der; Koning, K. de; Nielsen, M.; Tops, C.; Morreau, H.; Cappel, W.H.D.T.N.; Langers, A.M.J.; Hardwick, J.C.; Gaarenstroom, K.N.; Tollenaar, R.A.; Veenendaal, R.A.; Tibben, A.; Wijnen, J.; Heck, M. van; Asperen, C. van; Roukema, A.J.; Hommes, D.W.; Hes, F.J. & Vasen, H.F.A. (2013), Value-based healthcare in Lynch syndrome, Familial Cancer 12(2): 347-354.
- Schaafsma, B.E.; Verbeek, F.P.R.; Peters, A.A.W.; Vorst, J.R. van der; Kroon, C.D. de; Poelgeest, M.I.E. van; Trimbos, J.B.M.Z.; Velde, C.J.H. van de; Frangioni, J.V.; Vahrmeijer, A.L. & Gaarenstroom, K.N. (2013), Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers, BJOG: An International Journal of Obstetrics and Gynaecology 120(6): 758-764.
- Schaafsma, B.E.; Vorst, J.R. van der; Gaarenstroom, K.N.; Peters, A.A.W.; Verbeek, F.P.R.; Kroon, C.D. de; Trimbos, J.B.M.Z.; Poelgeest, M.I.E. van; Frangioni, J.V.; Velde, C.J.H. van de & Vahrmeijer, A.L. (2012), Randomized comparison of near-infrared fluorescence lymphatic tracers for sentinel lymph node mapping of cervical cancer, Gynecologic Oncology 127(1): 126-130.
- Hutteman, M.; Vorst, J.R. van der; Gaarenstroom, K.N.; Peters, A.A.W.; Mieog, J.S.D.; Schaafsma, B.E.; Lowik, C.W.G.M.; Frangioni, J.V.; Velde, C.J.H. van de & Vahrmeijer, A.L. (2012), Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer, American Journal of Obstetrics and Gynecology 206(1): -.
- Rutten, M.J.; Gaarenstroom, K.N.; Gorp, T. van; Meurs, H.S. van; Arts, H.J.G.; Bossuyt, P.M.; Brugge, H.G. ter; Hermans, R.H.M.; Opmeer, B.C.; Pijnenborg, J.M.A.; Schreuder, H.W.R.; Schutter, E.M.J.; Spijkerboer, A.M.; Wensveen, C.W.M.; Zusterzeel, P.; Mol, B.W.J.; Kenter, G.G. & Buist, M.R. (2012), Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study, BMC Cancer 12: -.
- Vorst, J.R. van der; Hutteman, M.; Gaarenstroom, K.N.; Peters, A.A.W.; Mieog, J.S.D.; Schaafsma, B.E.; Kuppen, P.J.K.; Frangioni, J.V.; Velde, C.J.H. van de & Vahrmeijer, A.L. (2011), Optimization of Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Cervical Cancer Patients.
- Cabenda-Narain, N.E.; Jansen, F.W.; Dieben, S.W.M.; Verburg, H.J. & Gaarenstroom, K.N. (2011), Conservatively treated borderline ovarian tumours, followed by IVF treatment: A case series, JOURNAL OF OBSTETRICS AND GYNAECOLOGY 31(4): 327-329.
- Wunderink, H.F.; Lashley, E.E.L.O.; Poelgeest, M.I.E. van; Gaarenstroom, K.N.; Claas, E.C.J. & Kuijper, E.J. (2011), Pelvic Actinomycosis-Like Disease Due to Propionibacterium propionicum after Hysteroscopic Removal of an Intrauterine Device, Journal of Clinical Microbiology 49(1): 466-468.
- Verleye, L.; Ottevanger, P.B.; Kristensen, G.B.; Ehlen, T.; Johnson, N.; Burg, M.E.L. van der; Reed, N.S.; Verheijen, R.H.M.; Gaarenstroom, K.N.; Mosgaard, B.; Seoane, J.M.; Velden, J. van der; Lotocki, R.; Graaf, W. van der; Penninckx, B.; Coens, C.; Stuart, G. & Vergote, I. (2011), Quality of pathology reports for advanced ovarian cancer: Are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial, European Journal of Cancer 47(1): 57-64.
- Kroon, C.D. de; Gaarenstroom, K.N.; Poelgeest, M.I.E. van; Peters, A.A. & Trimbos, J.B. (2010), Nerve Sparing in Radical Surgery for Early-Stage Cervical Cancer Yes We Should!, International Journal of Gynecological Cancer 20: S39S41.
- Kroon, C.D. de; Gaarenstroom, K.N.; Poelgeest, M.I.E. van; Peters, A.A. & Trimbos, J.B. (2010), Nerve sparing in radical surgery for early-stage cervical cancer: yes we should!, International Journal of Gynecological Cancer 20(11 Suppl 2): S39-41.
- Oonk, M.H.; Hemel, B.M. van; Hollema, H.; Hullu, J.A. de; Ansink, A.C.; Vergote, I.; Verheijen, R.H.; Maggioni, A.; Gaarenstroom, K.N.; Baldwin, P.J.; Dorst, E.B. van; Velden, J. van der; Hermans, R.H.; Putten, H.W. van der; Drouin, P.; Runnebaum, I.B.; Sluiter, W.J. & Zee, A.G. van der (2010), Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study, Lancet Oncology 11(7): 646-652.
- Sturgeon, C.M.; Duffy, M.J.; Hofmann, B.R.; Lamerz, R.; Fritsche, H.A.; Gaarenstroom, K.; Bonfrer, J.; Ecke, T.H.; Grossman, H.B.; Hayes, P.; Hoffmann, R.T.; Lerner, S.P.; Lohe, F.; Louhimo, J.; Sawczuk, I.; Taketa, K. & Diamandis, E.P. (2010), National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers, Clinical Chemistry 56(6): E1E48.
- Evans DG, Gaarenstroom KN, Stirling D, Shenton A, Maehle L, Dorum A, Steel M, Lalloo F, Apold J, Porteous ME, Vasen HFA, van Asperen CJ & Moller P (2009), Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers, Journal of Medical Genetics 46(9): 593-597.
- van den Tillaart SAHM, Kenter GG, Peters AAW, Dekker FW, Gaarenstroom KN, Fleuren GJ & Trimbos JBMZ (2009), Nerve-Sparing Radical Hysterectomy Local Recurrence Rate, Feasibility, and Safety in Cervical Cancer Patients Stage IA to IIA, International Journal of Gynecological Cancer 19(1): 39-45.
- van den Tillaart SA, Kenter GG, Peters AA, Dekker FW, Gaarenstroom KN, Fleuren GJ & Trimbos JB (2009), Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA., International Journal of Gynecological Cancer 19(1): 39-45.
- Van der Zee AGJ, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, Van Dorst EB, Van der Velden J, Hermans RH, van der Putten H, Drouin P, Schneider A & Sluiter WJ (2008), Sentinel node dissection is safe in the treatment of early-stage vulvar cancer, Journal of Clinical Oncology 26(6).
- Hermsen BBJ, Olivier RI, Verheijen RHM, van Beurden M, de Hullu JA, Massuger LF, Burger CW, Brekelmans CT, Mourits MJ, de Bock GH, Gaarenstroom KN, van Boven HH, Mooij TM & Rookus MA (2007), No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study, British Journal of Cancer 96(9).
- Pieterse QD, Kenter GG, Gaarenstroom KN, Peters AAW, Willems SM, Fleuren GJ & Trimbos JBMZ (2007), The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer, EJSO - European Journal of Surgical Oncology 33(2).
- Madalinska JB, van Beurden M, Bleiker EMA, Valdimarsdottir HB, Lubsen-Brandsma L, Massuger LF, Mourits MJE, Gaarenstroom KN, van Dorst EBL, van der Putten H, Boonstra H & Aaronson NK (2007), Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers, Journal of Clinical Oncology 25(3).
- Madalinska JB, van Beurden M, Bleiker EMA, Valdimarsdottir HB, Hollenstein J, Massuger LF, Gaarenstroom KN, Mourits MJE, Verheijen RHM, van Dorst EBL, van der Putten H, van der Velden K, Boonstra H & Aaronson NK (2006), The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy, Journal of Clinical Oncology 24(22).
- Pieterse QD, Trimbos JBMZ, Dijkman A, Creutzberg CL, Gaarenstroom KN, Peters AAW & Kenter GG (2006), Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study, International Journal of Gynecological Cancer 16(3).
- Gaarenstroom KN, van der Hiel B, Tollenaar RAEM, Vink GR, Jansen FW, Van Asperen CJ & Kenter GG (2006), Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study, International Journal of Gynecological Cancer 16.
- Elzevier HW, Gaarenstroom KN & Nijeholt AABLA (2005), Sexual function after partial cystectomy and urothelial stripping in a 32-year-old woman with radiation cystitis, International Urogynecology Journal 16(5).
- Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF, Gaarenstroom KN, Mourits MJE, Verheijen RHM, van Dorst EBL, van der Putten H, van der Velden K, Boonstra H & Aaronson NK (2005), Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer, Journal of Clinical Oncology 23(28).
- Trimbos JB, Lambeek AF, Petres AAW, Wolterbeek R, Gaarenstroom KN, Fleuren GJ & Kenter GG (2004), Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer, Gynecologic Oncology 95(1).
- Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AAW & Vergote I (2003), Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions, International Journal of Gynecological Cancer 13(4).
- Gaarenstroom KN, Kenter GG, Bonfrer JMG, Korse CM, Van de Vijver MJ, Fleuren GJ & Trimbos JB (2000), Can initial serum Cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
- Gaarenstroom KN, Bonfrer JMG, Korse CM, Kenter GG & Kenemans P (1997), Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer, Anticancer Research 17(4B): 2955-2958.
- Bonfrer JMG, Gaarenstroom KN, Korse CM, VanBunningen BNFM & Kenemans P (1997), Cyfra 21-1 in monitoring cervical cancer: A comparison with tissue polypeptide antigen and squamous cell carcinoma antigen, Anticancer Research 17(3C): 2329-2334.
- GAARENSTROOM KN, BONFRER JMG, KENTER GG, KORSE CM, HART AAM, TRIMBOS JB & HELMERHORST TJM (1995), CLINICAL-VALUE OF PRETREATMENT SERUM CYFRA-21-1, TISSUE POLYPEPTIDE ANTIGEN, AND SQUAMOUS-CELL CARCINOMA ANTIGEN LEVELS IN PATIENTS WITH CERVICAL-CANCER, Cancer 76(5): 807-813.
- BONFRER JMG, GAARENSTROOM KN, KENTER GG, KORSE CM, HART AAM, GALLEE MPW, HELMERHORST TJM & KENEMANS P (1994), PROGNOSTIC-SIGNIFICANCE OF SERUM FRAGMENTS OF CYTOKERATIN-19 MEASURED BY CYFRA-21-1 IN CERVICAL-CANCER, Gynecologic Oncology 55(3): 371-375.
- GAARENSTROOM KN, KENTER GG, BONFRER JMG, KORSE CM, GALLEE MPW, HART AAM, MULLER M, TRIMBOS JB & HELMERHORST TJM (1994), PROGNOSTIC-SIGNIFICANCE OF SERUM ANTIBODIES TO HUMAN PAPILLOMAVIRUS-16 E4 AND E7 PEPTIDES IN CERVICAL-CANCER, Cancer 74(8): 2307-2313.